Progress and Impact of U.S. Government Investments in Global Health Security

Progress and Impact of U.S. Government Investments in Global Health Security - Report 2022

The National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security (NBS)1 (2022) sets out a bold goal for the U.S. government efforts in global health security, to build demonstrated capacity across at least five technical areas in at least 50 countries and to catalyze a matching level of progress in another 50 countries. Demonstrated capacity is defined as achieving a level four on the World Health Organization (WHO) Joint External Evaluation (JEE) scale or 80 percent achievement on the WHO’s International Health Regulations Monitoring and Evaluation Framework (IHR MEF), or comparable level on other appropriate health security assessments. To reach this target the U.S. government emphasizes whole-of-government and whole-of-society efforts to build capacity at regional, national, and subnational levels to manage infectious disease outbreaks. Bilateral, multilateral, and regional engagement with partners and institutions is also critical to these efforts along with complementary U.S. investments in other areas like HIV/AIDS, malaria, and tuberculosis response and prevention, improving maternal and child health outcomes, furthering routine immunization, and strengthening health workforce capacities.